Evidence map›Paper›PMID 32517082›Full record

ArticleInternational journal of molecular sciences2020

Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.

Liadys Mora Lagares, Nikola Minovski, Ana Yisel Caballero Alfonso, Emilio Benfenati, Sara Wellens, Maxime Culot, Fabien Gosselet, Marjana Novič

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Regulation of P-Glycoprotein during Oxidative Stress.Antioxidants (Basel, Switzerland) · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Liadys Mora LagaresTheory Department, Laboratory for Cheminformatics, National Institute of Chemistry, 1000 Ljubljana, Slovenia.ORCID 0000-0002-6205-4675
Nikola MinovskiTheory Department, Laboratory for Cheminformatics, National Institute of Chemistry, 1000 Ljubljana, Slovenia.ORCID 0000-0003-0039-2246
Ana Yisel Caballero AlfonsoJožef Stefan International Postgraduate School, 1000 Ljubljana, Slovenia.
Emilio BenfenatiLaboratory of Environmental Chemistry and Toxicology, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche "Mario Negri"-IRCCS, 20156 Milano, Italy.
Sara WellensLaboratoire de la Barrière Hémato-Encéphalique (LBHE), Univ. Artois, UR 2465, F-62300 Lens, France.
Maxime CulotLaboratoire de la Barrière Hémato-Encéphalique (LBHE), Univ. Artois, UR 2465, F-62300 Lens, France.
Fabien GosseletLaboratoire de la Barrière Hémato-Encéphalique (LBHE), Univ. Artois, UR 2465, F-62300 Lens, France.ORCID 0000-0002-0481-5026
Marjana NovičTheory Department, Laboratory for Cheminformatics, National Institute of Chemistry, 1000 Ljubljana, Slovenia.
Université d'Artois · FRMario Negri Institute for Pharmacological Research · ITNational Institute of Chemistry · SIJožef Stefan International Postgraduate School · SI

Funding

H2020 Marie Skłodowska-Curie Actions 721975
6 · The paper itself

Abstract

The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of toxicity and possesses broad substrate specificity. It is involved in the failure of numerous anticancer and antiviral chemotherapies due to the multidrug resistance (MDR) phenomenon, where it removes the chemotherapeutics out of the targeted cells. Understanding the details of the ligand-P-gp interaction is therefore crucial for the development of drugs that might overcome the MRD phenomenon and for obtaining a more effective prediction of the toxicity of certain compounds. In this work, an in silico modeling was performed using homology modeling and molecular docking methods with the aim of better understanding the ligand-P-gp interactions. Based on different mouse P-gp structural templates from the PDB repository, a 3D model of the human P-gp (

Indexed as

Drug DiscoveryLigandsMolecular Docking SimulationMolecular Dynamics SimulationAnimalsAntineoplastic AgentsATP Binding Cassette Transporter, Subfamily B, Member 1Binding SitesDensity Functional TheoryHydrogen BondingProtein BindingProtein ConformationReproducibility of ResultsStructure-Activity RelationshipAntineoplastic AgentsATP Binding Cassette Transporter, Subfamily B, Member 1Ligandscaco-2 pump out assaymolecular dockingP-glycoproteinprotein homology modeling

Identifiers

PMID32517082
PMCPMC7312539
OpenAlexW3033304525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.